Dr. Daniel Kopans

Breast
Dr. Daniel Kopans: Will the USPSTF heed science on breast screening?
The U.S. Preventive Services Task Force (USPSTF) has begun a review of its guidelines on breast screening. Dr. Daniel Kopans believes the task force should heed the established science on mammography and recommend screening of women in their 40s.
January 28, 2021
2016 10 11 13 31 21 852 Am Second Opinion 400
Breast
Kopans: New NEJM paper offers rehash on 'overdiagnosis'
In this Second Opinion article, Dr. Daniel Kopans of Massachusetts General Hospital comments on a paper on breast screening by Welch et al published this week in the New England Journal of Medicine. The Welch paper is based on false assumptions and makes the same mistakes as a 2012 paper on the same topic, according to Kopans.
October 12, 2016
2016 10 11 13 31 21 852 Am Second Opinion 400
Breast
Kopans: JAMA Oncology paper misinterprets DCIS data
Just how deadly is ductal carcinoma in situ (DCIS)? A paper by Narod et al published on August 20 in JAMA Oncology suggests that the best way to deal with DCIS is simply to ignore it, rather than treating it aggressively. But such conclusions represent a dangerous misinterpretation of the actual data, according to Dr. Daniel Kopans.
August 23, 2015
2013 04 29 15 33 22 49 Kopans Daniel 200 20130429223516
Home
A response to Harding et al
The ploy used by Harding et al in their new study is classic. Explain why using your approach is scientifically unsupportable, and then go ahead and use it claiming there is no alternative.
July 5, 2015
Dr. Daniel Kopans from Massachusetts General Hospital.
Breast
Dr. Daniel Kopans: Topol ignores facts on mammography
In this Second Opinion article, Dr. Daniel Kopans of Massachusetts General Hospital offers a rebuttal of a May 6 column by cardiologist Dr. Eric Topol that calls for an end to routine mammography screening. Dr. Kopans believes the column misinterprets the facts about breast screening.
May 6, 2015
2013 06 03 12 02 47 211 Second Opinion Am 200
Breast
Dr. Daniel Kopans: On the draft USPSTF breast screening guidelines
In this Second Opinion article, Dr. Daniel Kopans offers his perspective on the release this week of new guidelines on screening mammography from the U.S. Preventive Services Task Force (USPSTF) -- guidelines that he believes will restrict access to mammography.
April 20, 2015
2013 06 03 12 02 47 211 Second Opinion Am 200
Breast
Kopans: Attacks on mammography are part of coordinated effort
In this Second Opinion article, breast imaging expert Dr. Daniel Kopans of Massachusetts General Hospital offers his perspective on the rising number of research studies with negative findings on screening mammography.
April 27, 2014
2013 06 03 12 02 47 211 Second Opinion Am 200
Breast
Kopans: Breast cancer overdiagnosis grossly exaggerated
In this Second Opinion article, breast imaging expert Dr. Daniel Kopans offers his rebuttal of a study published last November in the New England Journal of Medicine, which raised questions about the value of screening mammography and claimed that a third of detected breast cancers represent "overdiagnosis."
April 29, 2013
2013 04 29 15 33 22 49 Kopans Daniel 200 20130429223516
Breast
Shock and awe over JAMA editorial
The University of California, San Francisco researchers who authored this week's JAMA editorial on screening have disregarded the facts regarding the value of screening mammography, according to Dr. Daniel Kopans, who shares his view in this AuntMinnie Second Opinion.
October 21, 2009
2009 06 23 14 37 33 976 Second Opinion Am
Breast
DBT: Not a panacea, but promising technology is unfairly panned
The debate over the relative value of digital breast tomosynthesis (DBT) for cancer screening continues with Dr. Daniel Kopans, founder of the breast imaging division at Massachusetts General Hospital in Boston, who offers an opinion on the technology.
October 29, 2007
2007 10 01 09 05 35 706
Page 1 of 1
Top Stories
Ai Hand
Nuclear Medicine
LLMs rapidly evolving in nuclear medicine
Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.
2025 10 24 Jmri Said Fig2 Thumbnail
MRI
DWI with fat correction identifies liver scarring in MASLD patients
Emergency Sign
Ultrasound
Ghost scans problematic in POCUS trauma exams
Prostate Imaging
Molecular Imaging
PSMA-PET may require selective use to be cost-effective
Join Us!
Sponsor Content
Join Us!
More in Home
LLMs rapidly evolving in nuclear medicine
By Will Morton
Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.
October 24, 2025
Ai Hand
DWI with fat correction identifies liver scarring in MASLD patients
By Kate Madden Yee
An MRI technique that corrects for fat in the liver appears to perform comparably to MRE for detecting fibrosis.
October 24, 2025
2025 10 24 Jmri Said Fig2 Thumbnail
Ghost scans problematic in POCUS trauma exams
By Amerigo Allegretto
Rates of ghost scans -- where POCUS images are not saved -- vary by imaging facility, but are high overall in emergency settings.
October 24, 2025
Emergency Sign
PSMA-PET may require selective use to be cost-effective
By Will Morton
Yale University researcher developed a decision-analytic model to estimate lifetime cost outcomes associated with PSMA-PET.
October 24, 2025
Prostate Imaging
New procedure treats chronic pain in toe joints
By Will Morton
Median pain scores dropped for 27 patients from nine to one after five months.
October 23, 2025
Toe Joint
HPI study, online tool identify and predict cancer disparities
By Kate Madden Yee
Factors such as poverty and environmental toxins are some of the most common community-level predictors of U.S. cancer disparities.
October 23, 2025
Health Disparities Label Adobe Eco Lens
Radiology CSI: CT helps medical examiners determine cause of death
By Kate Madden Yee
Kalpana Kanal, PhD, of the University of Washington Medical Center in Seattle, spoke to AuntMinnie about forensic CT.
October 23, 2025
This image depicts comminuted skull fractures sustained in a pedestrian motor vehicle accident. These are difficult to document by a standard autopsy because the individual fragments are displaced during the internal examination and dissection of the head.
Radiomics plus DL improve prediction of lung cancer invasiveness
By Kate Madden Yee
This combined model could support better treatment planning for patients with early-stage disease.
October 22, 2025
Lung Cancer
False-negative breast exams on the rise
By Amerigo Allegretto
False-negative screening exams are rising among women, influenced by patient- and facility-level factors.
October 22, 2025
Mammo Reading 400
Is it time to put global health in radiology education curricula?
By Amerigo Allegretto
A lack of faculty expertise and less time in education curricula may hinder radiologist participation in global health efforts.
October 22, 2025
Globe Digital Screens
What’s the best treatment for 'eloquent' brain AVMs?
By Will Morton
Researchers performed the first direct comparisons of two emerging techniques for treating arteriovenous malformations (AVMs).
October 21, 2025
Brain Avms Thumbnail
Preop MRI lessens younger women's risk of breast cancer recurrence
By Amerigo Allegretto
Preoperative MRI may lead to lower risk of ipsilateral in-breast recurrence in younger women with newly diagnosed breast cancer.
October 21, 2025
Images in a 49-year-old patient originally treated for hormone receptor-positive invasive cancer without preoperative MRI who developed bloody nipple discharge two years after surgery. (A) Left mediolateral oblique mammogram shows new grouped pleomorphic calcification (arrow) adjacent to the previous operation site. (B) Transverse ultrasound image shows a 2.3-cm hypoechoic mass (arrows) with calcifications. (C) Axial contrast-enhanced fat-saturated T1-weighted MRI scan shows an irregular, heterogeneously enhancing mass (arrow) in the left breast, adjacent to the operation site. The final pathologic examination confirmed recurrent invasive ductal carcinoma.
Page 1 of 179
Next Page